Shopping Cart
Remove All
Your shopping cart is currently empty
Ozanezumab (GSK1223249) is a sophisticated humanized IgG1 monoclonal antibody target the neurite outgrowth inhibitor A (Nogo-A), thereby facilitating neuronal regeneration and functional recovery through high-affinity binding to its specific protein target for the research of amyotrophic lateral sclerosis and multiple sclerosis.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $372 | - | In Stock | |
| 5 mg | $1,090 | - | In Stock | |
| 10 mg | $1,780 | - | In Stock | |
| 25 mg | $3,290 | - | In Stock | |
| 50 mg | $5,290 | - | In Stock |
| Description | Ozanezumab (GSK1223249) is a sophisticated humanized IgG1 monoclonal antibody target the neurite outgrowth inhibitor A (Nogo-A), thereby facilitating neuronal regeneration and functional recovery through high-affinity binding to its specific protein target for the research of amyotrophic lateral sclerosis and multiple sclerosis. |
| Synonyms | GSK1223249 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | NOGO-A |
| Cas No. | 1310680-64-8 |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.